Petersen Irene, Phillips Andrew
Research Department of Primary Care and Population Health, University College London, London, UK.
Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Clin Epidemiol. 2020 Oct 8;12:1039-1043. doi: 10.2147/CLEP.S276825. eCollection 2020.
To reduce transmission of SARS-CoV-2, it is important to identify those who are infectious. However, little is known about what proportion of infectious people are asymptomatic and potential "silent" transmitters. We evaluated the value of COVID-19 symptoms as a marker for SARS-CoV-2 infection from a representative English survey.
We used data from the Office for National Statistics Coronavirus (COVID-19) Infection Survey pilot study. We estimated sensitivity, specificity, the proportion of asymptomatic cases (1 - sensitivity), positive predictive value (PPV) and negative predictive value (NPV) of COVID-19 symptoms as a marker of infection using results of the SARS-CoV-2 test as the "gold standard".
In total, there were 36,061 individuals with a SARS-CoV-2 test between 26 April and 27 June 2020. Of these, 625 (1.7%) reported symptoms on the day of the test. There were 115 (0.32%) with a positive SARS-CoV-2 test result. Of the 115, there were 27 (23.5%) who were symptomatic and 88 (76.5%) who were asymptomatic on the day of the test. Focusing on those with specific symptoms (cough, and/or fever, and/or loss of taste/smell), there were 158 (0.43%) with such symptoms on the day of the test. Of the 115 with a positive SARS-CoV-2, there were 16 (13.9%) reporting symptoms. In contrast, 99 (86.1%) did not report specific symptoms on the day of the test. The PPV for all symptoms was 4.3% and for the specific symptoms 10.1%. The specificity and NPV of symptoms were above 98%.
COVID-19 symptoms are poor markers of SARS-CoV-2. Thus, 76.5% of this random sample who tested positive reported no symptoms, and 86.1% reported none of those specific to COVID-19. A more widespread testing programme is necessary to capture "silent" transmission and potentially prevent and reduce future outbreaks.
为减少严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的传播,识别出具有传染性的人群很重要。然而,对于无症状感染者以及潜在的“隐性”传播者在所有感染者中所占的比例,我们却知之甚少。我们通过一项具有代表性的英国调查,评估了新冠病毒病(COVID-19)症状作为SARS-CoV-2感染标志物的价值。
我们使用了英国国家统计局冠状病毒(COVID-19)感染调查试点研究的数据。以SARS-CoV-2检测结果作为“金标准”,我们估计了COVID-19症状作为感染标志物的敏感性、特异性、无症状病例比例(1 - 敏感性)、阳性预测值(PPV)和阴性预测值(NPV)。
2020年4月26日至6月27日期间,共有36,061人接受了SARS-CoV-2检测。其中,625人(1.7%)在检测当天报告有症状。SARS-CoV-2检测结果呈阳性的有115人(0.32%)。在这115人中,检测当天有症状的27人(23.5%),无症状的88人(76.5%)。聚焦于有特定症状(咳嗽、和/或发热、和/或味觉/嗅觉丧失)的人群,检测当天有此类症状的有158人(0.43%)。在115例SARS-CoV-2检测呈阳性者中,报告有症状的16人(13.9%)。相比之下,99人(86.1%)在检测当天未报告特定症状。所有症状的PPV为4.3%,特定症状的PPV为10.1%。症状的特异性和NPV均高于98%。
COVID-19症状并非SARS-CoV-2的良好标志物。因此,在这个随机样本中,76.5%检测呈阳性者未报告有症状,86.1%未报告任何COVID-19的特定症状。有必要开展更广泛的检测计划,以捕捉“隐性”传播,并有可能预防和减少未来的疫情爆发。